497 related articles for article (PubMed ID: 10725339)
1. beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2.
DeFea KA; Zalevsky J; Thoma MS; Déry O; Mullins RD; Bunnett NW
J Cell Biol; 2000 Mar; 148(6):1267-81. PubMed ID: 10725339
[TBL] [Abstract][Full Text] [Related]
2. Activation and nuclear translocation of ERK1/2 by the formyl peptide receptor is regulated by G protein and is not dependent on beta-arrestin translocation or receptor endocytosis.
Gripentrog JM; Miettinen HM
Cell Signal; 2005 Oct; 17(10):1300-11. PubMed ID: 16038804
[TBL] [Abstract][Full Text] [Related]
3. A beta-arrestin-dependent scaffold is associated with prolonged MAPK activation in pseudopodia during protease-activated receptor-2-induced chemotaxis.
Ge L; Ly Y; Hollenberg M; DeFea K
J Biol Chem; 2003 Sep; 278(36):34418-26. PubMed ID: 12821670
[TBL] [Abstract][Full Text] [Related]
4. Stable interaction between beta-arrestin 2 and angiotensin type 1A receptor is required for beta-arrestin 2-mediated activation of extracellular signal-regulated kinases 1 and 2.
Wei H; Ahn S; Barnes WG; Lefkowitz RJ
J Biol Chem; 2004 Nov; 279(46):48255-61. PubMed ID: 15355986
[TBL] [Abstract][Full Text] [Related]
5. Trafficking of proteinase-activated receptor-2 and beta-arrestin-1 tagged with green fluorescent protein. beta-Arrestin-dependent endocytosis of a proteinase receptor.
Déry O; Thoma MS; Wong H; Grady EF; Bunnett NW
J Biol Chem; 1999 Jun; 274(26):18524-35. PubMed ID: 10373461
[TBL] [Abstract][Full Text] [Related]
6. The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation.
Tohgo A; Choy EW; Gesty-Palmer D; Pierce KL; Laporte S; Oakley RH; Caron MG; Lefkowitz RJ; Luttrell LM
J Biol Chem; 2003 Feb; 278(8):6258-67. PubMed ID: 12473660
[TBL] [Abstract][Full Text] [Related]
7. Arrestin regulates MAPK activation and prevents NADPH oxidase-dependent death of cells expressing CXCR2.
Zhao M; Wimmer A; Trieu K; Discipio RG; Schraufstatter IU
J Biol Chem; 2004 Nov; 279(47):49259-67. PubMed ID: 15364949
[TBL] [Abstract][Full Text] [Related]
8. beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation.
Tohgo A; Pierce KL; Choy EW; Lefkowitz RJ; Luttrell LM
J Biol Chem; 2002 Mar; 277(11):9429-36. PubMed ID: 11777902
[TBL] [Abstract][Full Text] [Related]
9. beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor.
Shenoy SK; Drake MT; Nelson CD; Houtz DA; Xiao K; Madabushi S; Reiter E; Premont RT; Lichtarge O; Lefkowitz RJ
J Biol Chem; 2006 Jan; 281(2):1261-73. PubMed ID: 16280323
[TBL] [Abstract][Full Text] [Related]
10. Multiple independent functions of arrestins in the regulation of protease-activated receptor-2 signaling and trafficking.
Stalheim L; Ding Y; Gullapalli A; Paing MM; Wolfe BL; Morris DR; Trejo J
Mol Pharmacol; 2005 Jan; 67(1):78-87. PubMed ID: 15475570
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of beta-arrestins on the internalization, desensitization and ERK1/2 activation downstream of protease activated receptor-2.
Kumar P; Lau CS; Mathur M; Wang P; DeFea KA
Am J Physiol Cell Physiol; 2007 Jul; 293(1):C346-57. PubMed ID: 17442737
[TBL] [Abstract][Full Text] [Related]
12. Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2.
Wei H; Ahn S; Shenoy SK; Karnik SS; Hunyady L; Luttrell LM; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2003 Sep; 100(19):10782-7. PubMed ID: 12949261
[TBL] [Abstract][Full Text] [Related]
13. Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation.
Gesty-Palmer D; Chen M; Reiter E; Ahn S; Nelson CD; Wang S; Eckhardt AE; Cowan CL; Spurney RF; Luttrell LM; Lefkowitz RJ
J Biol Chem; 2006 Apr; 281(16):10856-64. PubMed ID: 16492667
[TBL] [Abstract][Full Text] [Related]
14. Palmitoylation of the V2 vasopressin receptor carboxyl tail enhances beta-arrestin recruitment leading to efficient receptor endocytosis and ERK1/2 activation.
Charest PG; Bouvier M
J Biol Chem; 2003 Oct; 278(42):41541-51. PubMed ID: 12900404
[TBL] [Abstract][Full Text] [Related]
15. beta-Arrestin 2 expression determines the transcriptional response to lysophosphatidic acid stimulation in murine embryo fibroblasts.
Gesty-Palmer D; El Shewy H; Kohout TA; Luttrell LM
J Biol Chem; 2005 Sep; 280(37):32157-67. PubMed ID: 16027114
[TBL] [Abstract][Full Text] [Related]
16. Mast cell tryptase controls paracellular permeability of the intestine. Role of protease-activated receptor 2 and beta-arrestins.
Jacob C; Yang PC; Darmoul D; Amadesi S; Saito T; Cottrell GS; Coelho AM; Singh P; Grady EF; Perdue M; Bunnett NW
J Biol Chem; 2005 Sep; 280(36):31936-48. PubMed ID: 16027150
[TBL] [Abstract][Full Text] [Related]
17. Constitutive protease-activated receptor-2-mediated migration of MDA MB-231 breast cancer cells requires both beta-arrestin-1 and -2.
Ge L; Shenoy SK; Lefkowitz RJ; DeFea K
J Biol Chem; 2004 Dec; 279(53):55419-24. PubMed ID: 15489220
[TBL] [Abstract][Full Text] [Related]
18. Constitutive ERK1/2 activation by a chimeric neurokinin 1 receptor-beta-arrestin1 fusion protein. Probing the composition and function of the G protein-coupled receptor "signalsome".
Jafri F; El-Shewy HM; Lee MH; Kelly M; Luttrell DK; Luttrell LM
J Biol Chem; 2006 Jul; 281(28):19346-57. PubMed ID: 16670094
[TBL] [Abstract][Full Text] [Related]
19. Beta-arrestin inhibits CAMKKbeta-dependent AMPK activation downstream of protease-activated-receptor-2.
Wang P; Jiang Y; Wang Y; Shyy JY; DeFea KA
BMC Biochem; 2010 Sep; 11():36. PubMed ID: 20858278
[TBL] [Abstract][Full Text] [Related]
20. The role of beta-arrestins in the formyl peptide receptor-like 1 internalization and signaling.
Huet E; Boulay F; Barral S; Rabiet MJ
Cell Signal; 2007 Sep; 19(9):1939-48. PubMed ID: 17594911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
